These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 1888825

  • 1. The effect of ranitidine, cimetidine or famotidine on low-dose post-prandial alcohol absorption.
    Fraser AG, Prewett EJ, Hudson M, Sawyerr AM, Rosalki SB, Pounder RE.
    Aliment Pharmacol Ther; 1991 Jun; 5(3):263-72. PubMed ID: 1888825
    [Abstract] [Full Text] [Related]

  • 2. Ranitidine, cimetidine, famotidine have no effect on post-prandial absorption of ethanol 0.8 g/kg taken after an evening meal.
    Fraser AG, Hudson M, Sawyerr AM, Smith M, Rosalki SB, Pounder RE.
    Aliment Pharmacol Ther; 1992 Dec; 6(6):693-700. PubMed ID: 1362497
    [Abstract] [Full Text] [Related]

  • 3. Cimetidine and ranitidine. Lack of effect on the pharmacokinetics of an acute ethanol dose.
    Dauncey H, Chesher GB, Palmer RH.
    J Clin Gastroenterol; 1993 Oct; 17(3):189-94. PubMed ID: 8228077
    [Abstract] [Full Text] [Related]

  • 4. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
    Nwokolo CU, Smith JT, Gavey C, Sawyerr A, Pounder RE.
    Aliment Pharmacol Ther; 1990 Oct; 4 Suppl 1():29-45. PubMed ID: 1983345
    [Abstract] [Full Text] [Related]

  • 5. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
    Merki HS, Witzel L, Walt RP, Neumann J, Scheurle E, Mappes A, Krammisch H, Heim J, Kaufmann D, Roehmel J.
    Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
    [Abstract] [Full Text] [Related]

  • 6. Effects of ranitidine on blood alcohol levels after ethanol ingestion. Comparison with other H2-receptor antagonists.
    DiPadova C, Roine R, Frezza M, Gentry RT, Baraona E, Lieber CS.
    JAMA; 1992 Jan 01; 267(1):83-6. PubMed ID: 1727201
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of gastric alcohol dehydrogenase activity by histamine H2-receptor antagonists has no influence on the pharmacokinetics of ethanol after a moderate dose.
    Mallat A, Roudot-Thoraval F, Bergmann JF, Trout H, Simonneau G, Dutreuil C, Blanc LE, Dhumeaux D, Delchier JC.
    Br J Clin Pharmacol; 1994 Feb 01; 37(2):208-11. PubMed ID: 7910473
    [Abstract] [Full Text] [Related]

  • 8. Lack of effect of H2-receptor antagonists on the pharmacokinetics of alcohol consumed after food at lunchtime.
    Kendall MJ, Spannuth F, Walt RP, Gibson GJ, Hale KA, Braithwaite R, Langman MJ.
    Br J Clin Pharmacol; 1994 Apr 01; 37(4):371-4. PubMed ID: 8018458
    [Abstract] [Full Text] [Related]

  • 9. Comparative evaluation of the hemodynamic effects of oral cimetidine, ranitidine, and famotidine as determined by echocardiography.
    Welage LS, Dunn-Kucharski VA, Berardi RR, Shea MJ, Dechert RE, Bleske BE.
    Pharmacotherapy; 1995 Apr 01; 15(2):158-63. PubMed ID: 7624262
    [Abstract] [Full Text] [Related]

  • 10. Low-dose famotidine and ranitidine as single post-prandial doses: a three-period placebo-controlled comparative trial.
    Reilly TG, Singh S, Cottrell J, Mann SG, Stauffer L, Walt RP.
    Aliment Pharmacol Ther; 1996 Oct 01; 10(5):749-55. PubMed ID: 8899083
    [Abstract] [Full Text] [Related]

  • 11. Short report: the effect of ranitidine on the post-prandial absorption of a low dose of alcohol.
    Fraser AG, Hudson M, Sawyerr AM, Rosalki SB, Pounder RE.
    Aliment Pharmacol Ther; 1992 Apr 01; 6(2):267-71. PubMed ID: 1600045
    [Abstract] [Full Text] [Related]

  • 12. Impact of chronic oral H2-antagonist therapy on left ventricular systolic function and exercise capacity.
    Hilleman DE, Mohiuddin SM, Williams MA, Gannon JM, Mathias RJ, Thalken LJ.
    J Clin Pharmacol; 1992 Nov 01; 32(11):1033-7. PubMed ID: 1361935
    [Abstract] [Full Text] [Related]

  • 13. Prolonged bedtime treatment with H2-receptor antagonists (ranitidine and famotidine) does not affect blood alcohol levels after ethanol ingestion in male patients with duodenal ulcer.
    Casini A, Pizzigallo AM, Mari F, Bertol E, Surrenti C.
    Am J Gastroenterol; 1994 May 01; 89(5):745-9. PubMed ID: 8172150
    [Abstract] [Full Text] [Related]

  • 14. Pharmacodynamics of bolus famotidine versus infused cimetidine, ranitidine, and famotidine.
    Amsden GW, Goss TF, Harrison NJ, D'Andrea DT, Schentag JJ.
    J Clin Pharmacol; 1994 Dec 01; 34(12):1191-8. PubMed ID: 7738215
    [Abstract] [Full Text] [Related]

  • 15. Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists.
    Ahmadi A, Ebrahimzadeh MA, Ahmad-Ashrafi S, Karami M, Mahdavi MR, Saravi SS.
    Fundam Clin Pharmacol; 2011 Feb 01; 25(1):72-9. PubMed ID: 20070855
    [Abstract] [Full Text] [Related]

  • 16. [Inhibition of 24-hour acidity by nizatidine].
    Dammann HG, Dreyer M, Gottlieb WR, Wolf N, Müller P, Simon B.
    Fortschr Med; 1989 May 10; 107(14):321-4. PubMed ID: 2568971
    [Abstract] [Full Text] [Related]

  • 17. Low-dose famotidine and effervescent cimetidine in healthy subjects: a placebo-controlled overnight pH study.
    Reilly TG, Grimley CE, Usselmann B, Cottrell J, Mann SG, Raskin S, Nwokolo CU.
    Aliment Pharmacol Ther; 1998 May 10; 12(5):469-74. PubMed ID: 9663728
    [Abstract] [Full Text] [Related]

  • 18. Histamine-2 receptor antagonists do not alter serum ethanol levels in fed, nonalcoholic men.
    Raufman JP, Notar-Francesco V, Raffaniello RD, Straus EW.
    Ann Intern Med; 1993 Apr 01; 118(7):488-94. PubMed ID: 8095127
    [Abstract] [Full Text] [Related]

  • 19. Comparison of immunomodulative effects of the histamine-2 receptor antagonists cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells in gastric cancer patients.
    Hahm KB, Kim WH, Lee SI, Kang JK, Park IS.
    Scand J Gastroenterol; 1995 Mar 01; 30(3):265-71. PubMed ID: 7770717
    [Abstract] [Full Text] [Related]

  • 20. The effects of cimetidine, ranitidine and famotidine on the single-dose pharmacokinetics of naproxen and its metabolites in humans.
    Vree TB, van den Biggelaar-Martea M, Verwey-van Wissen CP, Vree ML, Guelen PJ.
    Int J Clin Pharmacol Ther Toxicol; 1993 Dec 01; 31(12):597-601. PubMed ID: 8314361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.